$75.50
0.640.85%
At close: Aug 11, 5:00 PM EST
$75.40
-0.1-0.13%
After Hours: 8:03 AM EST
Nektar Therapeutics
NKTRNASDAQ
Earnings: Q2 2026 earnings tomorrow on Thu Aug 13th after the market close
Nektar Therapeutics Earnings & Forecasts
Nektar Therapeutics (NKTR) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Nektar Therapeutics Guidance
Recent Earnings Results
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-1.53 | $-3.20 | $-2.81 | $-3.12 |
| Actual | $-1.82 | $-1.78 | $-1.87 | $-2.95 |
| Surprise | -18.9% | +44.4% | +33.5% | +5.45% |
| Revenue | ||||
| Estimate | $10.8M | $10.1M | $10.4M | $10.0M |
| Actual | $10.9M | $21.8M | $11.8M | $11.2M |
| Surprise | +0.28% | +116.8% | +13.9% | +12.2% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q2 '26E | Q3 '26E | Q4 '26E | Q1 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-2.02 | $-0.72 | $-2.59 | $-3.14 |
| Revenue | ||||
| Consensus | $10.5M | $10.3M | — | — |
